Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$1.08B |
| 2 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$324M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$281M |
| 4 |
DuPont de Nemours
DD
|
+$278M |
| 5 |
HCC
HCC INSURANCES HOLDINGS INC
HCC
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$830M |
| 2 |
Johnson & Johnson
JNJ
|
+$281M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$205M |
| 4 |
Bausch Health
BHC
|
+$183M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$182M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 4.85% |
| 2 | Technology | 3.93% |
| 3 | Financials | 3.3% |
| 4 | Energy | 3.26% |
| 5 | Communication Services | 2.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5826
Digital Turbine
APPS
$975M
| $6K | ﹤0.01% |
6,554
+5,623
| +604% | +$13.3K |
|
5827
Arcos Dorados Holdings
ARCO
$1.72B
| $6K | ﹤0.01% |
2,912
-23,345
| -89% | -$89.2K |
|
5828
Atara Biotherapeutics
ATRA
$75.5M
| $6K | ﹤0.01% |
8
-3
| -27% | -$3.66K |
|
5829
BancFirst
BANF
$3.79B
| $6K | ﹤0.01% |
188
-88
| -32% | -$2.77K |
|
5830
PUT
Broadridge
BR
$17.8B
| $6K | ﹤0.01% |
100
| – | – |
|
5831
Broadwind
BWEN
$93.6M
| $6K | ﹤0.01% |
2,761
+1,761
| +176% | +$5.88K |
|
5832
Cass Information Systems
CASS
$714M
| $6K | ﹤0.01% |
149
-1,063
| -88% | -$41.5K |
|
5833
CALL
CBRE Group
CBRE
$42.5B
| $6K | ﹤0.01% |
200
-4,200
| -95% | -$149K |
|
5834
PUT
ProShares Ultra Dow30
DDM
$542M
| $6K | ﹤0.01% |
600
-17,400
| -97% | -$180K |
|
5835
DHT Holdings
DHT
$2.99B
| $6K | ﹤0.01% |
898
-878
| -49% | -$6.76K |
|
5836
CALL
Enovis
ENOV
$1.68B
| $6K | ﹤0.01% |
116
-930
| -89% | -$61.7K |
|
5837
The Ensign Group
ENSG
$10.4B
| $6K | ﹤0.01% |
284
-757
| -73% | -$17.4K |
|
5838
Franklin Covey
FC
$242M
| $6K | ﹤0.01% |
342
-280
| -45% | -$4.83K |
|
|
FFIC
5839
DELISTED
Flushing Financial
FFIC
| $6K | ﹤0.01% |
278
-284
| -51% | -$5.81K |
|
|
KYNB
5840
Kyntra Bio
KYNB
$27.2M
| $6K | ﹤0.01% |
12
-27
| -69% | -$16.4K |
|
5841
First Merchants
FRME
$2.68B
| $6K | ﹤0.01% |
236
-579
| -71% | -$15K |
|
5842
PUT
Foster
FSTR
$430M
| $6K | ﹤0.01% |
500
| – | – |
|
5843
Greenlight Captial
GLRE
$552M
| $6K | ﹤0.01% |
272
-1,381
| -84% | -$36.2K |
|
|
HEES
5844
DELISTED
H&E Equipment Services
HEES
| $6K | ﹤0.01% |
352
-44,218
| -99% | -$777K |
|
5845
Helios Technologies
HLIO
$2.57B
| $6K | ﹤0.01% |
228
-205
| -47% | -$6.72K |
|
5846
Harmonic Inc
HLIT
$1.25B
| $6K | ﹤0.01% |
1,212
-861
| -42% | -$5.24K |
|
5847
Hope Bancorp
HOPE
$1.79B
| $6K | ﹤0.01% |
416
-1,106
| -73% | -$16.5K |
|
5848
HealthEquity
HQY
$8.41B
| $6K | ﹤0.01% |
190
-504
| -73% | -$15.8K |
|
5849
Independent Bank
INDB
$3.99B
| $6K | ﹤0.01% |
136
-364
| -73% | -$17K |
|
5850
Innospec
IOSP
$2.12B
| $6K | ﹤0.01% |
126
-1,139
| -90% | -$52.2K |
|
Similar funds
Barclays's Q3 2015 Portfolio in Review
As of Q3 2015, Barclays held 7,503 positions worth $82.9B, down 6.9% from $89.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays deployed $2.62B of net new capital in Q3 2015, opening 382 new positions and adding to 2,612 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, down from 6.6% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $830M trimmed.
- Barclays's largest Q3 2015 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
- Barclays added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $281M increase.
- Barclays's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $830M.
- Barclays fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $126M.
- Barclays's ten largest holdings make up 28% of its $82.9B portfolio in Q3 2015.
- Barclays opened 382 new positions and closed 515 in Q3 2015.
- Barclays's portfolio value fell 6.9% quarter-over-quarter to $82.9B.
Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.